ArticleCureus2025
Association Between Severity of COVID-19 Infection and Persistent Dyspnea in Recovered Adults: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction The COVID-19 pandemic has led to a high number of survivors with persistent symptoms, such as dyspnea, long after recovery. It is important to understand the association between the severity of the initial COVID-19 infection and the persistence of dyspnea to guide patient management and rehabilitation planning. Methods This cross-sectional analysis involved adult patients who had recovered from laboratory-confirmed COVID-19 infection. Patients were stratified into groups by the severity of their acute infection (mild, moderate, severe) based on the WHO Clinical Progression Scale. Persistent dyspnea was measured with a validated dyspnea scale. Statistical analysis was conducted to examine the association between COVID-19 severity and severity of dyspnea, adjusting for potential confounders. Results A total of 385 individuals took part in the study, where 217 people (56%) fell within the 30 to 39 years age bracket, while female participants constituted 52% (200 individuals). The respondents were primarily widowed people who had received secondary education (n = 119, 31%, and n = 118, 31% respectively). A total of 141 participants were current smokers, while 145 participants reported never smoking. Among the study participants, 73 experienced asthma (19%), and hypertension affected 68 individuals (18%). The COVID-19 severity of patients spanned from mild (n = 144, 37%) to critical (n = 78, 20%), and 51% of patients received hospital care (n = 197). Research findings indicated that dyspnea symptoms and advancement in the disease are closely linked (r = 0.521, p < 0.05). People who got oxygen therapy had higher clinical scores than those who did not (p = 0.01). When comparing the ICU patients to other patients, no important differences were noticed (p = 0.05). Recovery was felt very minimally in the results. According to regression analysis, changes in the patient's clinical condition were highly associated with dyspnea, as shown by a β value of 0.521 and p < 0.001. Conclusion The intensity of COVID-19 infection strongly correlates with both the enduring nature and severity of dyspnea in adults who have recovered from the disease. Post-COVID follow-up and rehabilitation programs require strong evidence behind them to support patients who have experienced severe COVID-19 infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.